Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01361425
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT01361425
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT01361425. Randomized; triple masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2012-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)
- Acronym
- METILDOPAPE
- Condition
- Preeclampsia
- Intervention (Drug)
- methildopa
- Intervention (Drug)
- placebo
- Lead sponsor
- Professor Fernando Figueira Integral Medicine Institute
- Collaborator
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Record details
- Record id
cardio:ct-nct01361425- Content hash
4abac111977a8d6216c9c7bf95c4511e675b7ff75ca77d80a34b04a92fcb502c